DUAL-HOTSTART
Live / Registered — Registered — Section 8 accepted (as of 16 Feb 2023)
What this means for you
Registered since 16 May 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86491548
- Registration number
- 5205321
- Mark type
- Stylized text
- Filed
- 29 Dec 2014
- Published for opposition
- 29 Dec 2015
- Registered
- 16 May 2017
- Attorney of record
- Jun-Hwa Jeong
Goods and services
- Class 001 — Chemicals: biological enzyme not for medical purposes; cDNA synthesizing compositions for research purpose; cDNA synthesizing kits for research purposes comprised primarily of reagents, buffers, reverse transcriptase and oligo; nucleic acid fluorescence staining compositions for research purpose; nucleic acid fluorescence staining kits for research purposes comprised primarily of reagents, buffers, and dyes; DNA sequence analyzing compositions for research purpose; DNA sequence analyzing kits for research purposes comprised primarily of reagents, buffers and DNA polymerase; nucleic acid polymerase for research purpose; nucleic acid amplifying compositions for research purpose; nucleic acid amplifying kits for research purposes comprised primarily of regents, buffers, and nucleic acid polymerase; chemical reagent for research purpose; restriction enzyme for research purpose; polymerase chain reaction compositions for research purpose; reverse transcription compositions for research purpose
- Class 005 — Pharmaceuticals: biological enzyme for medical purposes; cDNA synthesizing compositions for medical purposes; cDNA synthesizing kits for medical purposes comprised primarily of regents, buffers, reverse transcriptase and oligo; nucleic acid fluorescence staining compositions for medical purposes; nucleic acid fluorescence staining kits for medical purposes comprised primarily of reagents, buffers, and dyes; DNA sequence analyzing compositions for medical purposes; DNA sequence analyzing kits for medical purpose comprised primarily of reagents, buffers and DNA polymerase; nucleic acid polymerase for medical purposes; nucleic acid amplifying compositions for medical purposes; nucleic acid amplifying kits for medical purposes comprised primarily of reagents, buffers, and nucleic acid polymerase; chemical reagent for medical purposes; restriction enzyme for medical purposes; polymerase chain reaction compositions for medical purposes; reverse transcription compositions for medical purposes
Owner
- BIONEER CORPORATION, Daejeon, KR
- BIONEER CORPORATION, Daejeon, KR
- BIONEER CORPORATION, Daejeon, KR
Prosecution history
- 16 Feb 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 16 Feb 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 15 Feb 2023 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 06 Jan 2023 — POST REGISTRATION ACTION MAILED - SEC. 8
- 06 Jan 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 12 Jul 2022 — TEAS SECTION 8 RECEIVED
- 16 May 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 16 May 2017 — REGISTERED-PRINCIPAL REGISTER
- 08 Apr 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 07 Apr 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Oct 2016 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 13 Oct 2016 — NON-FINAL ACTION E-MAILED
- 13 Oct 2016 — SU - NON-FINAL ACTION - WRITTEN
- 22 Sept 2016 — STATEMENT OF USE PROCESSING COMPLETE
- 15 Aug 2016 — USE AMENDMENT FILED